Author: Zhao, Hui; Liu, Feng; Xie, Wei; Zhou, Tai-Cheng; OuYang, Jun; Jin, Lian; Li, Hui; Zhao, Chun-Yan; Zhang, Liang; Wei, Jia; Zhang, Ya-Ping; Li, Can-Peng
Title: Ultrasensitive supersandwich-type electrochemical sensor for SARS-CoV-2 from the infected COVID-19 patients using a smartphone Cord-id: nfit5kv0 Document date: 2020_9_14
ID: nfit5kv0
Snippet: The recent pandemic outbreak of COVID-19 caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses a threat to public health globally. Thus, developing a rapid, accurate, and easy-to-implement diagnostic system for SARS-CoV-2 is crucial for controlling infection sources and monitoring illness progression. Here, we reported an ultrasensitive electrochemical detection technology using calixarene functionalized graphene oxide for targeting RNA of SARS-CoV-2. Based on a s
Document: The recent pandemic outbreak of COVID-19 caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses a threat to public health globally. Thus, developing a rapid, accurate, and easy-to-implement diagnostic system for SARS-CoV-2 is crucial for controlling infection sources and monitoring illness progression. Here, we reported an ultrasensitive electrochemical detection technology using calixarene functionalized graphene oxide for targeting RNA of SARS-CoV-2. Based on a supersandwich-type recognition strategy, the technology was confirmed to practicably detect the RNA of SARS-CoV-2 without RNA amplification and reverse-transcription by using a portable electrochemical smartphone. The biosensor showed high specificity and selectivity during in silico analysis and actual testing. A total of 88 RNA extracts from 25 SARS-CoV-2-confirmed patients and eight recovery patients were detected using the biosensor. The detectable ratios (85.5% and 46.2%) were higher than those obtained using RT-qPCR (56.5% and 7.7%). The limit of detection (LOD) of the clinical specimen was 200 copies/mL, which is the lowest LOD among the published RNA measurement of SARS-CoV-2 to date. Additionally, only two copies (10 μL) of SARS-CoV-2 were required for per assay. Therefore, we developed an ultrasensitive, accurate, and convenient assay for SARS-CoV-2 detection, providing a potential method for point-of-care testing.
Search related documents:
Co phrase search for related documents- accurate diagnosis and acid biosensor: 1
- accurate diagnosis and lod detection: 1, 2, 3, 4, 5
- accurate diagnosis and low concentration: 1, 2
- accurate diagnosis and low number: 1, 2, 3, 4, 5
- accurate early and acid amplification: 1, 2, 3, 4, 5, 6, 7
- accurate early diagnostic and acid amplification: 1
- acid amplification and lod detection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acid amplification and low concentration: 1, 2, 3, 4
- acid amplification and low number: 1, 2, 3
- acid biosensor and lod detection: 1
- lod detection and low concentration: 1, 2, 3, 4, 5, 6
- lod detection and low number: 1, 2
Co phrase search for related documents, hyperlinks ordered by date